Ofichem Header Ofichem Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Faran Shimi Pharmaceutical.

    Client Virtual Booth

    FARAN SHIMI PHARMACEUTICAL

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    • 3-O-Methyl Norbuprenorphine

    • Buprenorphine

    • Buprenorphine Hydrochloride

    • Codeine

    • Codeine Phosphate

    • Methadone

    • Methadone Hydrochloride

    • Morphine Hydrochloride

    • Morphine Sulfate

    • Morphine Tartrate

    • Naloxone Hydrochloride

    • Naltrexone

    • Naltrexone Hydrochloride

    • Opium

    • Saffron Extract

    • Tramadol Hydrochloride
    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pluviaendo
    Faran Shimi Pharmaceutical
    Iran Flag
    Country
    Country
    Iran
    Address
    Address
    No. 3, Alley Kaveh, NiroEntezami St .Attar Sq. Tehran
    Telephone
    Telephone
    +98 2188208535
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://faranshimi.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/faranshimi/
    Twitter
    Twitter
    Contact Info
    Others

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran

    Details:

    Under the terms of the agreement, Faran will receive the exclusive rights to market Firibastat for the treatment of difficult-to-treat / resistant hypertension in Greece.


    Lead Product(s): Firibastat

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: QGC001

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Recipient: Quantum Genomics

    Deal Size: Undisclosed Upfront Cash: $12.1 million

    Deal Type: Collaboration December 15, 2020

    Pluviaendo

    APGA Annual Conference

    Not Confirmed

    envelop Contact Supplier
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Pluviaendo

    APGA Annual Conference

    Not Confirmed

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search